B-luc MIA PaCa-2_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Please input keywords

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

B-luc MIA PaCa-2

Common name	B-luc MIA PaCa-2	Catalog number	310674
Aliases	NA	Disease	Pancreas carcinoma
Organism	Human	Strain	NA
Tissue types	Bone marrow	Tissue	Bone marrow

Description

This B-luc MIA PaCa-2 cell line expresses firefly luciferase as a marker of MIA PaCa-2 cells. Luminescence can be observed B-luc MIA PaCa-2 cells.

Application

B-luc MIA PaCa-2 cell line can be used to evaluate anti-cancer drugs in pancreas carcinoma in vivo.

Targeting strategy

Gene targeting strategy for B-luc MIA PaCa-2. The stop-CAG-Pr-luciferase-PA- LoxP-PuroR- LoxP sequence was inserted in the AAVS1 locus of wild-type MIA PaCa-2.

In vivo Imaging Analysis

from clipboard

Tumor growth and in vivo imaging of B-luc MIA PaCa-2 cells. B-luc MIA PaCa-2 cells were subcutaneously inoculated into BALB/c nude mice . After the tumors were grown to appropriate size, the subcutaneous tumors were excised into small pieces and transplanted into BALB/c nude mouse pancreas in situ. Signal intensity and body weight were measured twice a week. (A) Imaging was performed on days 7, 13, 17, 24, and 31, (B) Mice body weight (Mean ± SEM). B-luc MIA PaCa-2 cells can be used for in vivo efficacy evaluation.

Quantitative imaging data & body weight changes

from clipboard

Tumor growth and in vivo imaging of B-luc MIA PaCa-2 cells. B-luc MIA PaCa-2 cells (1x10⁷ and 2x10⁷) were subcutaneously implanted into the wild-type B-NDG mice. Signal intensity and body weight were measured twice a week. (A) Imaging was performed twice a week. (B) Body weight (Mean ± SEM). B-luc MIA PaCa-2 cells can be used for in vivo efficacy evaluation.